基于磁共振成像的影像组学预测低级别胶质瘤CCND1表达水平及预后
研究利用TCGA中412例低级别胶质瘤进行基因预后分析,并从TCIA选取149例MRI数据提取影像组学特征构建模型。CCND1为预后相关基因,高表达在晚期低级别胶质瘤中与生存获益相关(P<0.05)。LR和SVM模型预测CCND1表达的AUC在训练集为0.703和0.705,验证集为0.724和0.726。
要点
- CCND1在肿瘤与正常样本中差异表达,为低级别胶质瘤预后相关基因。
- CCND1高表达在晚期低级别胶质瘤中与生存获益相关(P<0.05)。
- 基于4个最优影像组学特征构建的LR和SVM模型可预测CCND1表达,验证集AUC分别为0.724和0.726。
核心结论
- CCND1表达升高可能影响低级别胶质瘤患者预后,基于MRI的影像组学模型可用于预测CCND1表达水平并理解其与预后的相关性。
研究设计与样本
- 研究论文;基因预后分析使用TCGA的412例低级别胶质瘤病例;影像组学分析从TCIA选取149例具有TCGA基因组数据的MRI病例,提取特征后用逻辑回归和 support vector machine 构建模型。
诊断标准与关键数值
- 逻辑回归模型预测CCND1表达的AUC在训练集为0.703、验证集为0.724;支持向量机模型在训练集为0.705、验证集为0.726;选取4个最优影像组学特征构建模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OJECTIVES: Low-grade glioma (LGG) is associated with increased mortality owing to recrudescence and the tendency for malignant transformation. Therefore, it is imperative to discover novel prognostic biomarkers as existing traditional prognostic biomarkers of glioma, including clinicopathological features and imaging examinations, are unable to meet the clinical demand for precision medicine. Accordingly, we aimed to evaluate the prognostic value of cyclin D1 (CCND1) expression levels and construct radiomic models to predict these levels in patients with LGG MATERIALS AND METHODS: A total of 412 LGG cases from The Cancer Genome Atlas (TCGA) were used for gene-based prognostic analysis. Using magnetic resonance imaging (MRI) images stored in The Cancer Imaging Archive with genomic data from TCGA, 149 cases were selected for radiomics feature extraction and model construction. After feature extraction, the radiomic signature was constructed using logistic regression (LR) and support vector machine (SVM) analyses.
RESULTS: CCND1 was identified as a prognosis-related gene with differential expression in tumor and normal samples and plays a role in regulating both the cell cycle and immune response. Landmark analysis revealed that high-expression levels of CCND1 were beneficial for survival (P < 0.05) in advanced LGG. Four optimal radiomics features were selected to construct radiomics models. The performance of LR and SVM achieved areas under the curve of 0.703 and 0.705, as well as 0.724 and 0.726 in the training and validation sets, respectively.
CONCLUSION: Elevated levels of CCND1 expression could impact the prognosis of patients with LGG. MRI-based radiomics, especially the AUC values, can serve as a novel tool for predicting CCND1 expression and understanding the correlation between elevated CCND1 expression and prognosis.
AVAILABILITY OF DATA AND MATERIALS: The datasets analyzed during the current study are available in the TCGA, TCIA, UCSC XENA and GTEx repository, https://portal.gdc.cancer.gov/, https://www.cancerimagingarchive.net/, https://xenabrowser.net/datapages/, https://www.gtexportal.org/home/.
引用
- Zhao K, Zhang H, Lin J, et al. Radiomic Prediction of CCND1 Expression Levels and Prognosis in Low-grade Glioma Based on Magnetic Resonance Imaging. Acad Radiol. 2024. PMID: 38824087. doi:10.1016/j.acra.2024.03.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。